DXB 0.74% 34.3¢ dimerix limited

DXB Media thread., page-13

  1. 1,114 Posts.
    lightbulb Created with Sketch. 294
    Hey Owl vs Fox

    I missed your re-post on my thread. Yes converting options is good move but this can easily go higher >$1.0 post mid-March result but I wouldn't be selling anytime soon as I'm counting high efficacy (80%) on clinical trial but this will also back-test eGFR result (of course it is double blinded which may not be available to us).

    The China NMPA has already endorsed trial for ACTION-3 phase 2 (refer to last announcement-Clinical sites on mainland China are intended for Part 2 of the FSGS ACTION3 Phase 3 clinical trial currently recruiting in 11 other countries). The post mid-march result (I'm guessing end or March or early April) is pivotal in the sense that DXB will potentially receive additional payment from Advanz to secure commercialisation of DXB 200 and almost certain to get 2 additional commercial deals from China and US. This will also entail

    • No Capital raise requirement to complete Phase 2 and 3 of ACTION-3
    • Much better commercial deals in US and China compared to Advanz
    • R & D payment reimbursement
    • SP appreciation of many folds

    DXB investment could be life changing as it is targeting Billion Dollar Market with no alternative medication available atm, but DYOR before any buy or sell and trust your investment. I'm not financial advisor.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
34.3¢
Change
0.003(0.74%)
Mkt cap ! $186.8M
Open High Low Value Volume
33.5¢ 34.5¢ 33.5¢ $263.1K 778.8K

Buyers (Bids)

No. Vol. Price($)
2 25043 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 92951 4
View Market Depth
Last trade - 14.29pm 23/05/2024 (20 minute delay) ?
Last
34.0¢
  Change
0.003 ( 0.00 %)
Open High Low Volume
34.0¢ 34.5¢ 33.5¢ 403932
Last updated 14.37pm 23/05/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.